ClinicalTrials.Veeva

Menu

Extended High-frequency Hearing and Speech Perception

B

Brian Monson

Status

Enrolling

Conditions

Low-pass Filtering Speech

Treatments

Diagnostic Test: Reduced extended high-frequency audibility

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05435989
R01DC019745 (U.S. NIH Grant/Contract)
AH181

Details and patient eligibility

About

This study examines the effects of low-pass filtering speech on speech perception.

Enrollment

480 estimated patients

Sex

All

Ages

19 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • native speakers of American English
  • normal hearing 250-8000 Hz

Exclusion criteria

  • non-native speakers of American English
  • hearing loss

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

480 participants in 1 patient group

Normal-hearing listeners
Experimental group
Treatment:
Diagnostic Test: Reduced extended high-frequency audibility

Trial contacts and locations

1

Loading...

Central trial contact

Brian Monson, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems